C$42.13
+2.48%
N/A+C$1.02
Healthcare
Medical - Pharmaceuticals
TSX
Active Trading
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, ...
Loading analysis...
Profitability
Net MarginN/A
Operating MarginN/A
Valuation
P/E RatioN/A
Current RatioN/A
Efficiency
ROEN/A
ROAN/A
Fundamental Analysis
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
Key Strengths
- Industry-leading gross margins
- Strong cash flow generation
- High R&D investment ratio
- Market leadership in AI chips
Risk Factors
- Premium valuation multiples
- Semiconductor cycle exposure
- Intense competition
- Geographic concentration
Market Cap vs Revenue & Earnings
Earnings
n/a
Revenue
n/a
Market cap
C$1.45T
n/a
P/E Ratio
n/a
P/S Ratio
Earnings & Revenue
Last Reportedn/a
Earnings per share (EPS)n/a
Gross Marginn/a
Net Profit Marginn/a
Debt/Equity Ration/a
Profitability Bridge (Current vs YoY)
How gross, operating and net margins shifted versus last year.
Revenue / Net Income / FCF History (USD B)
Growth Signals
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | Flat |
| Diluted EPS | — | — | — | — | Flat |
| Free Cash Flow | — | — | — | — | Flat |
Profitability
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Net Margin | — | — | — | — | Flat |
| Operating Margin | — | — | — | — | Flat |
| ROE | — | — | — | — | Flat |
Financial Health
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Current Ratio | — | — | — | — | Flat |
| Quick Ratio | — | — | — | — | Flat |
| Debt / Equity | — | — | — | — | Flat |
Valuation
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| P/E | — | — | — | — | Flat |
| P/B | — | — | — | — | Flat |